Can Donor-Derived Cell-Free DNA Detect Graft-Versus-Host Disease in Solid Organ Transplantation: A Case Report.

[1]  C. Sensen,et al.  Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms , 2020, International journal of molecular sciences.

[2]  M. Stegall,et al.  Chronic graft‐versus‐host disease in pancreas after kidney transplant recipients – An unrecognized entity , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  C. Thongprayoon,et al.  The Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection and Injury Status , 2020, Journal of clinical medicine.

[4]  J. Dipersio,et al.  The use of ruxolitinib for acute graft‐versus‐host disease developing after solid organ transplantation , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  A. Thorne,et al.  Donor-specific Cell-free DNA as a Biomarker in Solid Organ Transplantation. A Systematic Review , 2019, Transplantation.

[6]  Abel J Bronkhorst,et al.  The diverse origins of circulating cell‐free DNA in the human body: a critical re‐evaluation of the literature , 2018, Biological reviews of the Cambridge Philosophical Society.

[7]  L. Raida,et al.  Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence , 2018, Mediators of inflammation.

[8]  J. Sninsky,et al.  Cell-Free DNA and Active Rejection in Kidney Allografts. , 2017, Journal of the American Society of Nephrology : JASN.

[9]  D. Abramowicz,et al.  Cell‐Free DNA: An Upcoming Biomarker in Transplantation , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  P. Ruiz,et al.  Solid organ transplant-associated acute graft-versus-host disease. , 2010, Archives of pathology & laboratory medicine.

[11]  E. Holler,et al.  Graft-versus-host disease , 2009, The Lancet.

[12]  Guochun Wang,et al.  Elevated plasma cfDNA may be associated with active lupus nephritis and partially attributed to abnormal regulation of neutrophil extracellular traps (NETs) in patients with systemic lupus erythematosus. , 2014, Internal medicine.